Upload 4 files

BioASQ-train-list-9_v2synergy-snippet-annotated.json

@@ -0,0 +1,1285 @@
+{
+  "version": "BioASQ9_v2synergy",
+  "data": [
+    {
+      "paragraphs": [
+        {
+          "context": "SARS-CoV-2 infection is transmitted through droplets; though hypothesized, other transmission routes have not been confirmed",
+          "qas": [
+            {
+              "id": "60926bf5335f7e8227000005_002_001",
+              "question": "what are the transmission routes of coronavirus?",
+              "answers": [
+                {
+                  "text": "droplets",
+                  "answer_start": 44
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "The major transmission routes of SARS-CoV-2 are recognised as inhalation of aerosol/droplets and person-to-person contact",
+          "qas": [
+            {
+              "id": "60926bf5335f7e8227000005_017_001",
+              "question": "what are the transmission routes of coronavirus?",
+              "answers": [
+                {
+                  "text": "droplets",
+                  "answer_start": 84
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "The main routes of transmission of SARS-CoV-2 are physical contact with infected persons and exposure to respiratory droplets",
+          "qas": [
+            {
+              "id": "60926bf5335f7e8227000005_022_001",
+              "question": "what are the transmission routes of coronavirus?",
+              "answers": [
+                {
+                  "text": "droplets",
+                  "answer_start": 117
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "The person-to-person transmission routes of 2019-nCoV includes direct transmission, such as cough, sneeze, droplet inhalation transmission, and contact transmission, such as the contact with oral, nasal and eye mucous membranes.",
+          "qas": [
+            {
+              "id": "60926bf5335f7e8227000005_046_001",
+              "question": "what are the transmission routes of coronavirus?",
+              "answers": [
+                {
+                  "text": "sneeze",
+                  "answer_start": 99
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "The person-to-person transmission routes of 2019-nCoV included direct transmission, such as cough, sneeze, droplet inhalation transmission, and contact transmission, such as the contact with oral, nasal, and eye mucous membranes.",
+          "qas": [
+            {
+              "id": "60926bf5335f7e8227000005_056_001",
+              "question": "what are the transmission routes of coronavirus?",
+              "answers": [
+                {
+                  "text": "sneeze",
+                  "answer_start": 99
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "As a result of this unprecedented effort, two vaccine candidates, mRNA-1273 (Moderna, Cambridge, MA) and BNT162b2 (Pfizer, New York, NY), have been found to be safe and more than 90% effective in preventing symptomatic COVID-19 shortly after vaccination",
+          "qas": [
+            {
+              "id": "60926ac5335f7e8227000001_002_001",
+              "question": "What vaccine candidates are being tested for Covid-19?",
+              "answers": [
+                {
+                  "text": "mRNA-1273",
+                  "answer_start": 66
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "As a result of this unprecedented effort, two vaccine candidates, mRNA-1273 (Moderna, Cambridge, MA) and BNT162b2 (Pfizer, New York, NY), have been found to be safe and more than 90% effective in preventing symptomatic COVID-19 shortly after vaccination",
+          "qas": [
+            {
+              "id": "60926ac5335f7e8227000001_003_001",
+              "question": "What vaccine candidates are being tested for Covid-19?",
+              "answers": [
+                {
+                  "text": "BNT162b2",
+                  "answer_start": 105
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "This preliminary dataset identified GRAd-COV2 as a potential COVID-19 vaccine candidate, supporting the translation of GRAd-COV2 vaccine in a currently ongoing Phase I clinical trial (NCT04528641).",
+          "qas": [
+            {
+              "id": "60926ac5335f7e8227000001_004_001",
+              "question": "What vaccine candidates are being tested for Covid-19?",
+              "answers": [
+                {
+                  "text": "GRAd-COV2",
+                  "answer_start": 36
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "This preliminary dataset identified GRAd-COV2 as a potential COVID-19 vaccine candidate, supporting the translation of GRAd-COV2 vaccine in a currently ongoing Phase I clinical trial (NCT04528641).",
+          "qas": [
+            {
+              "id": "60926ac5335f7e8227000001_004_002",
+              "question": "What vaccine candidates are being tested for Covid-19?",
+              "answers": [
+                {
+                  "text": "GRAd-COV2",
+                  "answer_start": 119
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "In less than one year since the outbreak of the COVID-19 pandemic, two mRNA-based vaccines, BNT162b2 and mRNA-1273, were granted the first historic authorization for emergency use, while another mRNA vaccine, CVnCoV, progressed to phase 3 clinical testing.",
+          "qas": [
+            {
+              "id": "60926ac5335f7e8227000001_002_001",
+              "question": "What vaccine candidates are being tested for Covid-19?",
+              "answers": [
+                {
+                  "text": "mRNA-1273",
+                  "answer_start": 105
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "In less than one year since the outbreak of the COVID-19 pandemic, two mRNA-based vaccines, BNT162b2 and mRNA-1273, were granted the first historic authorization for emergency use, while another mRNA vaccine, CVnCoV, progressed to phase 3 clinical testing.",
+          "qas": [
+            {
+              "id": "60926ac5335f7e8227000001_003_001",
+              "question": "What vaccine candidates are being tested for Covid-19?",
+              "answers": [
+                {
+                  "text": "BNT162b2",
+                  "answer_start": 92
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "In this report, we describe a case in which a young woman sustained a traumatic skull base injury during a nasopharyngeal swab for COVID\ufffd\ufffd\ufffd19.",
+          "qas": [
+            {
+              "id": "6098952e335f7e8227000054_002_001",
+              "question": "What are the complications of tCOVID-19 Nasopharyngeal Swab Test?",
+              "answers": [
+                {
+                  "text": "skull base injury",
+                  "answer_start": 80
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "This case report describes a significant complication of a routine COVID-19 swab in a previously fit and well young patient who developed preseptal cellulitis and an infraorbital abscess as a consequence of the mentioned nasal swabbing.",
+          "qas": [
+            {
+              "id": "6098952e335f7e8227000054_023_001",
+              "question": "What are the complications of tCOVID-19 Nasopharyngeal Swab Test?",
+              "answers": [
+                {
+                  "text": "preseptal cellulitis",
+                  "answer_start": 138
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "This case report describes a significant complication of a routine COVID-19 swab in a previously fit and well young patient who developed preseptal cellulitis and an infraorbital abscess as a consequence of the mentioned nasal swabbing.",
+          "qas": [
+            {
+              "id": "6098952e335f7e8227000054_024_001",
+              "question": "What are the complications of tCOVID-19 Nasopharyngeal Swab Test?",
+              "answers": [
+                {
+                  "text": "infraorbital abscess",
+                  "answer_start": 166
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "Other authors have previously reported various complications in connection with the use of nasal swabs, including retained swab fragments, epistaxis and cerebrospinal fluid leakage.",
+          "qas": [
+            {
+              "id": "6098952e335f7e8227000054_027_001",
+              "question": "What are the complications of tCOVID-19 Nasopharyngeal Swab Test?",
+              "answers": [
+                {
+                  "text": "epistaxis",
+                  "answer_start": 139
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "Preseptal cellulitis and infraorbital abscess as a complication of a routine COVID-19 swab.",
+          "qas": [
+            {
+              "id": "6098952e335f7e8227000054_036_001",
+              "question": "What are the complications of tCOVID-19 Nasopharyngeal Swab Test?",
+              "answers": [
+                {
+                  "text": "infraorbital abscess",
+                  "answer_start": 25
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "Rapidly spreading variants of SARS-CoV-2 that have arisen in the United Kingdom and South Africa share the spike N501Y substitution, which is of particular concern because it is located in the viral receptor binding site for cell entry and increases binding to the receptor",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_004_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "United Kingdom",
+                  "answer_start": 65
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "Rapidly spreading variants of SARS-CoV-2 that have arisen in the United Kingdom and South Africa share the spike N501Y substitution, which is of particular concern because it is located in the viral receptor binding site for cell entry and increases binding to the receptor",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_008_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "South Africa",
+                  "answer_start": 84
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "The emergence of SARS-CoV-2 variants with mutations in the spike protein, most recently circulating isolates from the United Kingdom (B.1.1.7) and Republic of South Africa (B.1.351), has led to lower neutralization from convalescent serum by pseudovirus neutralization (PsVN) assays and resistance to certain monoclonal antibodies",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_015_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.1.7",
+                  "answer_start": 134
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "The emergence of SARS-CoV-2 variants with mutations in the spike protein, most recently circulating isolates from the United Kingdom (B.1.1.7) and Republic of South Africa (B.1.351), has led to lower neutralization from convalescent serum by pseudovirus neutralization (PsVN) assays and resistance to certain monoclonal antibodies",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_018_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "United Kingdom",
+                  "answer_start": 118
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "The emergence of SARS-CoV-2 variants with mutations in the spike protein, most recently circulating isolates from the United Kingdom (B.1.1.7) and Republic of South Africa (B.1.351), has led to lower neutralization from convalescent serum by pseudovirus neutralization (PsVN) assays and resistance to certain monoclonal antibodies",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_020_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.351",
+                  "answer_start": 173
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "The emergence of SARS-CoV-2 variants with mutations in the spike protein, most recently circulating isolates from the United Kingdom (B.1.1.7) and Republic of South Africa (B.1.351), has led to lower neutralization from convalescent serum by pseudovirus neutralization (PsVN) assays and resistance to certain monoclonal antibodies",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_022_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "South Africa",
+                  "answer_start": 159
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "For both B.1.1.7 and B.1351 variants, named as variants of concern (VOC), increased transmissibility was reported, whereas B.1.351 was more resistant to multiple monoclonal antibodies (mAbs), as well as convalescent and vaccination sera.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_029_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.1.7",
+                  "answer_start": 9
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "For both B.1.1.7 and B.1351 variants, named as variants of concern (VOC), increased transmissibility was reported, whereas B.1.351 was more resistant to multiple monoclonal antibodies (mAbs), as well as convalescent and vaccination sera.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_034_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.351",
+                  "answer_start": 123
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "With the global transmission of the virus, a large number of SARS-CoV-2 variants have also appeared, especially, emerging strains that have recently been discovered in the United Kingdom (variant 20I/501Y.V1, lineage B.1.1.7), South Africa (variant 20H/501Y.V2, lineage B.1.351), and Brazil (variant 20 J/501Y.V3, and lineage P.1).",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_085_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.1.7",
+                  "answer_start": 217
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "With the global transmission of the virus, a large number of SARS-CoV-2 variants have also appeared, especially, emerging strains that have recently been discovered in the United Kingdom (variant 20I/501Y.V1, lineage B.1.1.7), South Africa (variant 20H/501Y.V2, lineage B.1.351), and Brazil (variant 20 J/501Y.V3, and lineage P.1).",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_086_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "20I/501Y.V1",
+                  "answer_start": 196
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "With the global transmission of the virus, a large number of SARS-CoV-2 variants have also appeared, especially, emerging strains that have recently been discovered in the United Kingdom (variant 20I/501Y.V1, lineage B.1.1.7), South Africa (variant 20H/501Y.V2, lineage B.1.351), and Brazil (variant 20 J/501Y.V3, and lineage P.1).",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_088_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "United Kingdom",
+                  "answer_start": 172
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "With the global transmission of the virus, a large number of SARS-CoV-2 variants have also appeared, especially, emerging strains that have recently been discovered in the United Kingdom (variant 20I/501Y.V1, lineage B.1.1.7), South Africa (variant 20H/501Y.V2, lineage B.1.351), and Brazil (variant 20 J/501Y.V3, and lineage P.1).",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_090_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.351",
+                  "answer_start": 270
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "With the global transmission of the virus, a large number of SARS-CoV-2 variants have also appeared, especially, emerging strains that have recently been discovered in the United Kingdom (variant 20I/501Y.V1, lineage B.1.1.7), South Africa (variant 20H/501Y.V2, lineage B.1.351), and Brazil (variant 20 J/501Y.V3, and lineage P.1).",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_091_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "20H/501Y",
+                  "answer_start": 249
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "With the global transmission of the virus, a large number of SARS-CoV-2 variants have also appeared, especially, emerging strains that have recently been discovered in the United Kingdom (variant 20I/501Y.V1, lineage B.1.1.7), South Africa (variant 20H/501Y.V2, lineage B.1.351), and Brazil (variant 20 J/501Y.V3, and lineage P.1).",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_092_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "South Africa",
+                  "answer_start": 227
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "With the global transmission of the virus, a large number of SARS-CoV-2 variants have also appeared, especially, emerging strains that have recently been discovered in the United Kingdom (variant 20I/501Y.V1, lineage B.1.1.7), South Africa (variant 20H/501Y.V2, lineage B.1.351), and Brazil (variant 20 J/501Y.V3, and lineage P.1).",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_093_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "501Y.V2",
+                  "answer_start": 253
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "With the global transmission of the virus, a large number of SARS-CoV-2 variants have also appeared, especially, emerging strains that have recently been discovered in the United Kingdom (variant 20I/501Y.V1, lineage B.1.1.7), South Africa (variant 20H/501Y.V2, lineage B.1.351), and Brazil (variant 20 J/501Y.V3, and lineage P.1).",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_095_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "P.1",
+                  "answer_start": 326
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "With the global transmission of the virus, a large number of SARS-CoV-2 variants have also appeared, especially, emerging strains that have recently been discovered in the United Kingdom (variant 20I/501Y.V1, lineage B.1.1.7), South Africa (variant 20H/501Y.V2, lineage B.1.351), and Brazil (variant 20 J/501Y.V3, and lineage P.1).",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_096_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "Brazil",
+                  "answer_start": 284
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "A new variant of SARS-CoV-2 B.1.351 lineage (first found in South Africa) has been raising global concern due to its harboring of multiple mutations in the spike that potentially increase transmissibility and yield resistance to neutralizing antibodies.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_118_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.351",
+                  "answer_start": 28
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "A new variant of SARS-CoV-2 B.1.351 lineage (first found in South Africa) has been raising global concern due to its harboring of multiple mutations in the spike that potentially increase transmissibility and yield resistance to neutralizing antibodies.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_120_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "South Africa",
+                  "answer_start": 60
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "We compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_141_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.1.7",
+                  "answer_start": 47
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "We compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_146_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.351",
+                  "answer_start": 89
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "We compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_151_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "P.1",
+                  "answer_start": 105
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "OBJECTIVES: We sought to review current knowledge of emerging SARS-CoV-2 variants, particularly those deemed VOC/Is: B.1.351, B.1.1.7, and P.1.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_169_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.1.7",
+                  "answer_start": 126
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "OBJECTIVES: We sought to review current knowledge of emerging SARS-CoV-2 variants, particularly those deemed VOC/Is: B.1.351, B.1.1.7, and P.1.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_174_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.351",
+                  "answer_start": 117
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "OBJECTIVES: We sought to review current knowledge of emerging SARS-CoV-2 variants, particularly those deemed VOC/Is: B.1.351, B.1.1.7, and P.1.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_179_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "P.1",
+                  "answer_start": 139
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "Here, we describe a new SARS-CoV-2 lineage (501Y.V2) characterised by eight lineage-defining mutations in the spike protein, including three at important residues in the receptor-binding domain (K417N, E484K and N501Y) that may have functional significance3-5.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_191_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "501Y.V2",
+                  "answer_start": 44
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "At this current point in time there are 4 known major variants of the original SARS-CoV-2 virus, namely the English variant (B.1.1.7), the South African variant (B.1.351), Brazilian variants (VOC202101/02 (P.1) and VUI202101/01) and a variant similar to that of the South African variant found in North America (B.1.526), all of which have varying levels of resistance and infectivity.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_197_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.1.7",
+                  "answer_start": 125
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "At this current point in time there are 4 known major variants of the original SARS-CoV-2 virus, namely the English variant (B.1.1.7), the South African variant (B.1.351), Brazilian variants (VOC202101/02 (P.1) and VUI202101/01) and a variant similar to that of the South African variant found in North America (B.1.526), all of which have varying levels of resistance and infectivity.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_202_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.351",
+                  "answer_start": 162
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "At this current point in time there are 4 known major variants of the original SARS-CoV-2 virus, namely the English variant (B.1.1.7), the South African variant (B.1.351), Brazilian variants (VOC202101/02 (P.1) and VUI202101/01) and a variant similar to that of the South African variant found in North America (B.1.526), all of which have varying levels of resistance and infectivity.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_204_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "South Africa",
+                  "answer_start": 139
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "At this current point in time there are 4 known major variants of the original SARS-CoV-2 virus, namely the English variant (B.1.1.7), the South African variant (B.1.351), Brazilian variants (VOC202101/02 (P.1) and VUI202101/01) and a variant similar to that of the South African variant found in North America (B.1.526), all of which have varying levels of resistance and infectivity.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_204_002",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "South Africa",
+                  "answer_start": 266
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "At this current point in time there are 4 known major variants of the original SARS-CoV-2 virus, namely the English variant (B.1.1.7), the South African variant (B.1.351), Brazilian variants (VOC202101/02 (P.1) and VUI202101/01) and a variant similar to that of the South African variant found in North America (B.1.526), all of which have varying levels of resistance and infectivity.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_207_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "P.1",
+                  "answer_start": 206
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "At this current point in time there are 4 known major variants of the original SARS-CoV-2 virus, namely the English variant (B.1.1.7), the South African variant (B.1.351), Brazilian variants (VOC202101/02 (P.1) and VUI202101/01) and a variant similar to that of the South African variant found in North America (B.1.526), all of which have varying levels of resistance and infectivity.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_208_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "Brazil",
+                  "answer_start": 172
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "The novel SARS-CoV-2 Variant of Concern (VOC)-202012/01 (also known as B.1.1.7), first collected in United Kingdom on 20 September 2020, is a rapidly growing lineage that in January 2021 constituted 86% of all SARS-CoV-2 genomes sequenced in England.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_211_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.1.7",
+                  "answer_start": 71
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "The novel SARS-CoV-2 Variant of Concern (VOC)-202012/01 (also known as B.1.1.7), first collected in United Kingdom on 20 September 2020, is a rapidly growing lineage that in January 2021 constituted 86% of all SARS-CoV-2 genomes sequenced in England.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_214_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "United Kingdom",
+                  "answer_start": 100
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "In less than one year since the outbreak of the COVID-19 pandemic, two mRNA-based vaccines, BNT162b2 and mRNA-1273, were granted the first historic authorization for emergency use, while another mRNA vaccine, CVnCoV, progressed to phase 3 clinical testing.",
+          "qas": [
+            {
+              "id": "60926ac5335f7e8227000001_002_001",
+              "question": "What vaccine candidates are being tested for Covid-19?",
+              "answers": [
+                {
+                  "text": "mRNA-1273",
+                  "answer_start": 105
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "In less than one year since the outbreak of the COVID-19 pandemic, two mRNA-based vaccines, BNT162b2 and mRNA-1273, were granted the first historic authorization for emergency use, while another mRNA vaccine, CVnCoV, progressed to phase 3 clinical testing.",
+          "qas": [
+            {
+              "id": "60926ac5335f7e8227000001_003_001",
+              "question": "What vaccine candidates are being tested for Covid-19?",
+              "answers": [
+                {
+                  "text": "BNT162b2",
+                  "answer_start": 92
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "This case report describes a significant complication of a routine COVID-19 swab in a previously fit and well young patient who developed preseptal cellulitis and an infraorbital abscess as a consequence of the mentioned nasal swabbing.",
+          "qas": [
+            {
+              "id": "6098952e335f7e8227000054_011_001",
+              "question": "What are the complications of tCOVID-19 Nasopharyngeal Swab Test?",
+              "answers": [
+                {
+                  "text": "preseptal cellulitis",
+                  "answer_start": 138
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "This case report describes a significant complication of a routine COVID-19 swab in a previously fit and well young patient who developed preseptal cellulitis and an infraorbital abscess as a consequence of the mentioned nasal swabbing.",
+          "qas": [
+            {
+              "id": "6098952e335f7e8227000054_012_001",
+              "question": "What are the complications of tCOVID-19 Nasopharyngeal Swab Test?",
+              "answers": [
+                {
+                  "text": "infraorbital abscess",
+                  "answer_start": 166
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "Other authors have previously reported various complications in connection with the use of nasal swabs, including retained swab fragments, epistaxis and cerebrospinal fluid leakage.",
+          "qas": [
+            {
+              "id": "6098952e335f7e8227000054_015_001",
+              "question": "What are the complications of tCOVID-19 Nasopharyngeal Swab Test?",
+              "answers": [
+                {
+                  "text": "epistaxis",
+                  "answer_start": 139
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "Preseptal cellulitis and infraorbital abscess as a complication of a routine COVID-19 swab.",
+          "qas": [
+            {
+              "id": "6098952e335f7e8227000054_024_001",
+              "question": "What are the complications of tCOVID-19 Nasopharyngeal Swab Test?",
+              "answers": [
+                {
+                  "text": "infraorbital abscess",
+                  "answer_start": 25
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "This paper draws attention to a complication of viral swab testing in the nasopharynx and describes the premature engagement of a viral swab breakpoint, resulting in impaction in the nasal cavity.",
+          "qas": [
+            {
+              "id": "6098952e335f7e8227000054_031_001",
+              "question": "What are the complications of tCOVID-19 Nasopharyngeal Swab Test?",
+              "answers": [
+                {
+                  "text": "swab break",
+                  "answer_start": 136
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "We compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_001_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.1.7",
+                  "answer_start": 47
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "We compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_006_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.351",
+                  "answer_start": 89
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "We compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_011_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "P.1",
+                  "answer_start": 105
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "OBJECTIVES: We sought to review current knowledge of emerging SARS-CoV-2 variants, particularly those deemed VOC/Is: B.1.351, B.1.1.7, and P.1.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_029_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.1.7",
+                  "answer_start": 126
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "OBJECTIVES: We sought to review current knowledge of emerging SARS-CoV-2 variants, particularly those deemed VOC/Is: B.1.351, B.1.1.7, and P.1.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_034_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.351",
+                  "answer_start": 117
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "OBJECTIVES: We sought to review current knowledge of emerging SARS-CoV-2 variants, particularly those deemed VOC/Is: B.1.351, B.1.1.7, and P.1.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_039_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "P.1",
+                  "answer_start": 139
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "Here, we describe a new SARS-CoV-2 lineage (501Y.V2) characterised by eight lineage-defining mutations in the spike protein, including three at important residues in the receptor-binding domain (K417N, E484K and N501Y) that may have functional significance3-5.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_051_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "501Y.V2",
+                  "answer_start": 44
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "At this current point in time there are 4 known major variants of the original SARS-CoV-2 virus, namely the English variant (B.1.1.7), the South African variant (B.1.351), Brazilian variants (VOC202101/02 (P.1) and VUI202101/01) and a variant similar to that of the South African variant found in North America (B.1.526), all of which have varying levels of resistance and infectivity.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_057_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.1.7",
+                  "answer_start": 125
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "At this current point in time there are 4 known major variants of the original SARS-CoV-2 virus, namely the English variant (B.1.1.7), the South African variant (B.1.351), Brazilian variants (VOC202101/02 (P.1) and VUI202101/01) and a variant similar to that of the South African variant found in North America (B.1.526), all of which have varying levels of resistance and infectivity.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_062_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.351",
+                  "answer_start": 162
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "At this current point in time there are 4 known major variants of the original SARS-CoV-2 virus, namely the English variant (B.1.1.7), the South African variant (B.1.351), Brazilian variants (VOC202101/02 (P.1) and VUI202101/01) and a variant similar to that of the South African variant found in North America (B.1.526), all of which have varying levels of resistance and infectivity.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_064_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "South Africa",
+                  "answer_start": 139
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "At this current point in time there are 4 known major variants of the original SARS-CoV-2 virus, namely the English variant (B.1.1.7), the South African variant (B.1.351), Brazilian variants (VOC202101/02 (P.1) and VUI202101/01) and a variant similar to that of the South African variant found in North America (B.1.526), all of which have varying levels of resistance and infectivity.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_064_002",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "South Africa",
+                  "answer_start": 266
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "At this current point in time there are 4 known major variants of the original SARS-CoV-2 virus, namely the English variant (B.1.1.7), the South African variant (B.1.351), Brazilian variants (VOC202101/02 (P.1) and VUI202101/01) and a variant similar to that of the South African variant found in North America (B.1.526), all of which have varying levels of resistance and infectivity.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_067_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "P.1",
+                  "answer_start": 206
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "At this current point in time there are 4 known major variants of the original SARS-CoV-2 virus, namely the English variant (B.1.1.7), the South African variant (B.1.351), Brazilian variants (VOC202101/02 (P.1) and VUI202101/01) and a variant similar to that of the South African variant found in North America (B.1.526), all of which have varying levels of resistance and infectivity.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_068_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "Brazil",
+                  "answer_start": 172
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "The novel SARS-CoV-2 Variant of Concern (VOC)-202012/01 (also known as B.1.1.7), first collected in United Kingdom on 20 September 2020, is a rapidly growing lineage that in January 2021 constituted 86% of all SARS-CoV-2 genomes sequenced in England.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_071_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.1.7",
+                  "answer_start": 71
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "The novel SARS-CoV-2 Variant of Concern (VOC)-202012/01 (also known as B.1.1.7), first collected in United Kingdom on 20 September 2020, is a rapidly growing lineage that in January 2021 constituted 86% of all SARS-CoV-2 genomes sequenced in England.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_074_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "United Kingdom",
+                  "answer_start": 100
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "Currently, some new SARS-CoV-2 variants are circulating in Latin America and one among the significant variant belongs to the P.1 lineage (B.1.1.28.1) that has 17 mutations",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_095_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "P.1",
+                  "answer_start": 126
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "Currently, some new SARS-CoV-2 variants are circulating in Latin America and one among the significant variant belongs to the P.1 lineage (B.1.1.28.1) that has 17 mutations",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_097_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.1.28.1",
+                  "answer_start": 139
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "Some of the variants, especially the U.K. coronavirus variant (B.1.1.7), the South Africa variant (B.1.351), and the recently identified India variant (B.1.617) are more infectious and deadlier compared to SARS-CoV-2 before their appearance",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_099_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.1.7",
+                  "answer_start": 63
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "Some of the variants, especially the U.K. coronavirus variant (B.1.1.7), the South Africa variant (B.1.351), and the recently identified India variant (B.1.617) are more infectious and deadlier compared to SARS-CoV-2 before their appearance",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_104_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.351",
+                  "answer_start": 99
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "Some of the variants, especially the U.K. coronavirus variant (B.1.1.7), the South Africa variant (B.1.351), and the recently identified India variant (B.1.617) are more infectious and deadlier compared to SARS-CoV-2 before their appearance",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_106_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "South Africa",
+                  "answer_start": 77
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "The emergence of SARS-CoV-2 variants, as observed with the D614G spike protein mutant and, more recently, with B.1.1.7 (501Y.V1), B.1.351 (501Y.V2) and B.1.1.28.1 (P.1) lineages, represent a continuous threat and might lead to strains of higher infectivity and/or virulence.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_141_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.1.7",
+                  "answer_start": 111
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "The emergence of SARS-CoV-2 variants, as observed with the D614G spike protein mutant and, more recently, with B.1.1.7 (501Y.V1), B.1.351 (501Y.V2) and B.1.1.28.1 (P.1) lineages, represent a continuous threat and might lead to strains of higher infectivity and/or virulence.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_146_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.351",
+                  "answer_start": 130
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "The emergence of SARS-CoV-2 variants, as observed with the D614G spike protein mutant and, more recently, with B.1.1.7 (501Y.V1), B.1.351 (501Y.V2) and B.1.1.28.1 (P.1) lineages, represent a continuous threat and might lead to strains of higher infectivity and/or virulence.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_149_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "501Y.V2",
+                  "answer_start": 139
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "The emergence of SARS-CoV-2 variants, as observed with the D614G spike protein mutant and, more recently, with B.1.1.7 (501Y.V1), B.1.351 (501Y.V2) and B.1.1.28.1 (P.1) lineages, represent a continuous threat and might lead to strains of higher infectivity and/or virulence.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_151_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "P.1",
+                  "answer_start": 164
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "The emergence of SARS-CoV-2 variants, as observed with the D614G spike protein mutant and, more recently, with B.1.1.7 (501Y.V1), B.1.351 (501Y.V2) and B.1.1.28.1 (P.1) lineages, represent a continuous threat and might lead to strains of higher infectivity and/or virulence.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_153_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.1.28.1",
+                  "answer_start": 152
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "Some of the variants, especially the U.K. coronavirus variant (B.1.1.7), the South Africa variant (B.1.351), and the recently identified India variant (B.1.617) are more infectious and deadlier compared to SARS-CoV-2 before their appearance.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_155_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.1.7",
+                  "answer_start": 63
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "Some of the variants, especially the U.K. coronavirus variant (B.1.1.7), the South Africa variant (B.1.351), and the recently identified India variant (B.1.617) are more infectious and deadlier compared to SARS-CoV-2 before their appearance.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_160_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "B.1.351",
+                  "answer_start": 99
+                }
+              ]
+            }
+          ]
+        },
+        {
+          "context": "Some of the variants, especially the U.K. coronavirus variant (B.1.1.7), the South Africa variant (B.1.351), and the recently identified India variant (B.1.617) are more infectious and deadlier compared to SARS-CoV-2 before their appearance.",
+          "qas": [
+            {
+              "id": "6097a81c335f7e8227000049_162_001",
+              "question": "What are some of the important SARS-CoV-2 variants?",
+              "answers": [
+                {
+                  "text": "South Africa",
+                  "answer_start": 77
+                }
+              ]
+            }
+          ]
+        }
+      ],
+      "title": "BioASQ9_v2synergy"
+    }
+  ]
+}